- Home
- FATE vs DCGO Comparison
FATE vs DCGO Comparison
Compare FATE & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- DCGO
- Stock Information
- Founded
- FATE 2007
- DCGO 2015
- Country
- FATE United States
- DCGO United States
- Employees
- FATE N/A
- DCGO N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- DCGO Managed Health Care
- Sector
- FATE Health Care
- DCGO Health Care
- Exchange
- FATE Nasdaq
- DCGO Nasdaq
- Market Cap
- FATE 116.5M
- DCGO 139.7M
- IPO Year
- FATE 2013
- DCGO N/A
- Fundamental
- Price
- FATE $0.96
- DCGO $1.56
- Analyst Decision
- FATE Hold
- DCGO Strong Buy
- Analyst Count
- FATE 6
- DCGO 4
- Target Price
- FATE $3.30
- DCGO $3.78
- AVG Volume (30 Days)
- FATE 1.4M
- DCGO 321.8K
- Earning Date
- FATE 11-11-2025
- DCGO 11-06-2025
- Dividend Yield
- FATE N/A
- DCGO N/A
- EPS Growth
- FATE N/A
- DCGO N/A
- EPS
- FATE N/A
- DCGO N/A
- Revenue
- FATE $8,470,000.00
- DCGO $435,968,564.00
- Revenue This Year
- FATE N/A
- DCGO N/A
- Revenue Next Year
- FATE N/A
- DCGO N/A
- P/E Ratio
- FATE N/A
- DCGO N/A
- Revenue Growth
- FATE N/A
- DCGO N/A
- 52 Week Low
- FATE $0.66
- DCGO $1.23
- 52 Week High
- FATE $4.20
- DCGO $5.68
- Technical
- Relative Strength Index (RSI)
- FATE 40.20
- DCGO 49.80
- Support Level
- FATE $0.93
- DCGO $1.48
- Resistance Level
- FATE $1.08
- DCGO $1.61
- Average True Range (ATR)
- FATE 0.06
- DCGO 0.07
- MACD
- FATE -0.01
- DCGO -0.01
- Stochastic Oscillator
- FATE 11.22
- DCGO 41.46
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.